Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-08-07 00:00:00 ET · period of report 2025-07-15 · accession 0001415889-25-021271 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-08-07 | 2025-08-05 | KNSA | Tessari Eben | COO | M - OptEx | $11.44 | +138.6K | 177.9K | +353% | +$1.59M |
| DM | 2025-08-07 | 2025-08-05 | KNSA | Tessari Eben | COO | S - Sale+OE | $33.20 | -138.6K | 49.9K | -74% | -$4.60M |
| D | 2025-08-07 | 2025-07-15 | KNSA | Tessari Eben | COO | A - Grant | $15.63 | +752 | 49.9K | +2% | +$11.8K |
| DM | 2025-08-07 | 2025-08-05 | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -138.6K | 31.9K | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-08-05 | M | A | 30,444 | $12.97 | 119,287 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-08-05 | M | A | 32,710 | $11.10 | 151,997 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-08-05 | M | A | 10,636 | $10.76 | 188,529 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2025-08-05 | S | D | 138,064 | $33.20 | 50,465 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.83 and $33.82. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Common | Class A Ordinary Share | 2025-08-05 | S | D | 550 | $33.90 | 49,915 | D | — | — | (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $33.83 and $33.98. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 6 | Common | Class A Ordinary Share | 2025-08-05 | M | A | 38,928 | $10.36 | 88,843 | D | — | — | |
| 7 | Common | Class A Ordinary Share | 2025-07-15 | A | A | 752 | $15.63 | 49,915 | D | — | — | |
| 8 | Common | Class A Ordinary Share | 2025-08-05 | M | A | 25,896 | $11.97 | 177,893 | D | — | — | |
| 9 | Derivative | Share Option | 2025-08-05 | M | D | 38,928 | $0.00 | 0 | D | $10.36 · — to 2028-02-29 | 38,928 Class A Ordinary Share | (F5) The option is fully vested and exercisable. |
| 10 | Derivative | Share Option | 2025-08-05 | M | D | 30,444 | $0.00 | 16,694 | D | $12.97 · — to 2031-09-01 | 30,444 Class A Ordinary Share | (F6) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. |
| 11 | Derivative | Share Option | 2025-08-05 | M | D | 32,710 | $0.00 | 32,710 | D | $11.10 · — to 2032-04-06 | 32,710 Class A Ordinary Share | (F7) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022. |
| 12 | Derivative | Share Option | 2025-08-05 | M | D | 25,896 | $0.00 | 39,524 | D | $11.97 · — to 2032-08-31 | 25,896 Class A Ordinary Share | (F8) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022. |
| 13 | Derivative | Share Option | 2025-08-05 | M | D | 10,636 | $0.00 | 31,908 | D | $10.76 · — to 2033-03-31 | 10,636 Class A Ordinary Share | (F9) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2023. |